The effects of inflammation on lipid accumulation in the kidneys of children with primary nephrotic syndrome

Inflammation

Volumn 34, Issue 6, 2011, Pages 645-652

  Zhang, Gaofu ^a,b   Li, Qiu ^a,b   Wang, Li ^a   Chen, Yaxi ^b   Zhang, Wei ^a   Yang, Haiping ^a  

^a CHILDREN S HOSPITAL OF CHONGQING MEDICAL UNIVERSITY   (China)

^b CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

children; inflammation; lipid accumulation; low density lipoprotein receptor; primary nephrotic syndrome

Indexed keywords

APOLIPOPROTEIN B100; BINDING PROTEIN; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; INTERLEUKIN 1BETA; LIPID; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR; STEROL REGULATORY ELEMENT BINDING PROTEIN 2; STEROL REGULATORY ELEMENT BINDING PROTEIN CLEAVAGE ACTIVATING PROTEIN; TRANSFORMING GROWTH FACTOR BETA1; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ARTICLE; CHILD; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEEDBACK SYSTEM; FEMALE; GLOMERULOSCLEROSIS; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; JUXTAGLOMERULAR CELL; KIDNEY FIBROSIS; KIDNEY TUBULE CELL; LIPID BLOOD LEVEL; LIPID METABOLISM; LIPID STORAGE; MAJOR CLINICAL STUDY; MALE; MINIMAL CHANGE NEPHROTIC SYNDROME; NEPHROTIC SYNDROME; NON MINIMAL CHANGE NEPHROTIC SYNDROME; PERIODIC ACID SCHIFF STAIN; PRESCHOOL CHILD; PRIMARY NEPHROTIC SYNDROME; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; SCHOOL CHILD; SIGNAL TRANSDUCTION; UPREGULATION;

CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFLAMMATION; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; KIDNEY; LIPID METABOLISM; MALE; MEMBRANE PROTEINS; NEPHROTIC SYNDROME; RECEPTORS, LDL; STEROL REGULATORY ELEMENT BINDING PROTEIN 2;

EID: 82955188694     PISSN: 03603997     EISSN: 15732576     Source Type: Journal    
DOI: 10.1007/s10753-010-9274-4     Document Type: Article

References (23)

1. H Ahmad A Tejani 2000 Predictive value of repeat renal biopsies in children with nephrotic syndrome Nephron 84 342 346 10754411 10.1159/000045609 1:STN:280:DC%2BD3cvhsV2htA%3D%3D (Pubitemid 30179459)
2. R Cunard CJ Kelly 2002 T cells and minimal change disease Journal of the American Society of Nephrology 13 1409 1411 11961031 10.1097/01.ASN.0000016406. 82019.B3 (Pubitemid 34441424)
3. B Rodriguez-Iturbe J Herrera-Acosta RJ Johnson 2002 Interstitial inflammation, sodium retention, and the pathogenesis of nephrotic edema: A unifying hypothesis Kidney International 62 1379 1384 12234309 10.1111/j.1523-1755.2002.kid561.x 1:CAS:528:DC%2BD38XotVSnu74%3D
4. CY Lin 2004 Chien JW.Increased interleukin-12 release from peripheral blood mononuclear cells in nephrotic phase of minimal change nephrotic syndrome Acta Paediatrica Taiwanica 45 77 80 15335115
5. D Habashy EM Hodson JC Craig 2003 Interventions for steroid-resistant nephrotic syndrome: A systematic review Pediatric Nephrology 18 9 906 912 12836096 10.1007/s00467-003-1207-0 (Pubitemid 37121624)
6. JR Diamond MJ Karnovsky 1988 Focal and segmental glomerulosclerosis: Analogies to atherosclerosis Kidney International 33 917 924 3292816 10.1038/ki.1988.87 1:CAS:528:DyaL1cXktVCmtbs%3D
7. WF Keane BL Kasiske MP O'Donnell Y Kim 1991 The role of altered lipid metabolism in the progression of renal disease: Experimental evidence American Journal of Kidney Diseases 17 38 42 2024671 1:CAS:528:DyaK3MXmtVCmsLo%3D
8. CK Abrass 2004 Cellular lipid metabolism and the role of lipids in progressive renal disease American Journal of Nephrology 24 46 53 14707435 10.1159/000075925 1:CAS:528:DC%2BD2cXht1ahtL8%3D (Pubitemid 38258276)
9. H Ohtani K Matoba Y Saika R Tanaka Y Yamada K Bando T Takahashi M Mune S Yukawa H Nomoto 1990 Glomerular apolipoprotein B deposition in glomerular diseases Nippon Jinzo Gakkai Shi 32 1145 1152 2082049 1:CAS:528: DyaK3MXktVKnsLw%3D
10. H Sato S Suzuki M Ueno H Shimada R Karasawa S Nishi M Arakawa 1993 Localization of apolipoprotein (a) and B-100 in various renal diseases Kidney International 43 430 435 8441239 10.1038/ki.1993.63 1:STN:280: DyaK3s7otVersA%3D%3D (Pubitemid 23162838)
11. HS Lee JS Lee HI Koh KW Ko 1991 Intraglomerular lipid deposition in routine biopsies Clinical Nephrology 36 67 75 1934662 1:STN:280: DyaK38%2FjsFyjtg%3D%3D
12. T Takemura K Yoshioka N Aya K Murakami A Matumoto H Itakura T Kodama H Suzuki S Maki 1993 Apolipoproteins and lipoprotein receptors in glomeruli in human kidney diseases Kidney International 43 918 927 8479130 10.1038/ki.1993.129 1:STN:280:DyaK3s3ktVOltg%3D%3D (Pubitemid 23105228)
13. MS Brown JL Goldstein 1986 A receptor-mediated pathway for cholesterol homeostasis Science 232 34 47 3513311 10.1126/science.3513311 1:CAS:528:DyaL28Xhs1GrtbY%3D (Pubitemid 16037973)
14. JL Goldstein MS Brown 1985 The LDL receptor and the regulation of cellular cholesterol metabolism Journal of Cell Science. Supplement 3 131 137 3914990 1:CAS:528:DyaL28XhvVelu74%3D (Pubitemid 16137523)
15. XZ Ruan Z Varghese R Fernando JF Moorhead 1998 Cytokine regulation of low-density lipoprotein receptor gene transcription in human mesangial cells Nephrology, Dialysis, Transplantation 13 1391 1397 9641167 10.1093/ndt/13.6.1391 1:CAS:528:DyaK1cXktFeksbk%3D (Pubitemid 28254312)
16. XZ Ruan Z Varghese SH Powis JF Moorhead 2001 Dysregulation of LDL receptor under the influence of inflammatory cytokines: A new pathway for foam cell formation Kidney International 60 1716 1725 11703589 10.1046/j.1523-1755. 2001.00025.x 1:CAS:528:DC%2BD3MXotlGnsbw%3D (Pubitemid 32999976)
17. XZ Ruan JF Moorhead JL Tao KL Ma DC Wheeler SH Powis Z Varghese 2006 Mechanisms of dysregulation of low-density lipoprotein receptor expression in vascular smooth muscle cells by inflammatory cytokines Arteriosclerosis, Thrombosis, and Vascular Biology 26 1150 1155 16543490 10.1161/01.ATV. 0000217957.93135.c2 1:CAS:528:DC%2BD28XjsVersb0%3D (Pubitemid 43732126)
18. B Rodriguez-Iturbe Y Quiroz A Shahkarami Z Li ND Vaziri 2005 Mycophenolate mofetil ameliorates nephropathy in the obese Zucker rat Kidney International 68 1041 1047 16105034 10.1111/j.1523-1755.2005.00496.x 1:CAS:528:DC%2BD2MXhtVCjt7zI (Pubitemid 43246420)
19. J Qin Z Zhang J Liu L Sun L Hu ME Cooper Z Cao 2003 Effects of the combination of an angiotensin II antagonist with an HMG-CoA reductase inhibitor in experimental diabetes Kidney International 64 565 571 12846751 10.1046/j.1523-1755.2003.00127.x 1:CAS:528:DC%2BD3sXmsFyku7c%3D (Pubitemid 36871927)
20. SL Seliger 2006 Inflammation and dyslipidemia in nephropathy: An epidemiologic perspective Kidney International 69 206 208 16408107 10.1038/sj.ki.5000111 1:STN:280:DC%2BD28%2FitVOisQ%3D%3D (Pubitemid 43323067)
21. XZ Ruan Z Varghese 2003 Moorhead JF.Inflammation modifies lipid-mediated renal injury Nephrology, Dialysis, Transplantation 18 27 32 12480956 10.1093/ndt/18.1.27 (Pubitemid 36104475)
22. R Franzen A Pautz L Brautigam G Geisslinger J Pfeilschifter A Huwiler 2001 Interleukin-1beta induces chronic activation and de novo synthesis of neutral ceramidase in renal mesangial cells The Journal of Biological Chemistry 276 35382 35389 11457826 10.1074/jbc.M102153200 1:CAS:528:DC%2BD3MXntFaiu7o%3D
23. JB Kopp VM Factor M Mozes P Nagy N Sanderson EP Bottinger PE Klotman SS Thorgeirsson 1996 Transgenic mice with increased plasma levels of TGF-beta 1 develop progressive renal disease Laboratory Investigation 74 991 1003 8667617 1:CAS:528:DyaK28Xkt1Knsb0%3D (Pubitemid 26182412)